Dolby Laboratories (DLB) EBITDA (2009 - 2026)

Dolby Laboratories (DLB) has reported EBITDA for 18 consecutive years, with $34.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA fell 27.97% year-over-year to $34.3 million; the trailing twelve-month figure through Jun 2026 stood at $239.1 million (down 15.1% YoY), and the FY2025 full-year result was $265.0 million, up 2.57% from the prior year.
• EBITDA declined to $34.3 million in Q2 2026 per DLB's latest filing, from $112.9 million in the prior quarter.
• Across five years, EBITDA topped out at $112.9 million in Q1 2026 and bottomed at -$3.5 million in Q3 2023.
• Historically, EBITDA has averaged $59.1 million across 5 years, with a median of $47.0 million in 2024.
• The sharpest annual moves came in 2023 and 2024: EBITDA slumped 112.89% in 2023, then soared 1426.67% in 2024.
• Over 5 years, EBITDA stood at $94.1 million in 2022, then slipped by 29.62% to $66.2 million in 2023, then gained by 20.63% to $79.9 million in 2024, then dropped by 22.18% to $62.2 million in 2025, then slumped by 44.79% to $34.3 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $34.3 million, $112.9 million, and $62.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.